Iwona Cicha Selected Research

leukocyte procoagulant activity

1/2017

Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iwona Cicha Research Topics

Disease

6	Neoplasms (Cancer) 05/2022 - 01/2015
6	Atherosclerosis 01/2018 - 05/2005
6	Atherosclerotic Plaque (Atheroma) 01/2018 - 04/2004
3	Hemorrhage 08/2015 - 06/2007
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2015 - 02/2012
3	Stroke (Strokes) 03/2014 - 10/2009
2	Thrombosis (Thrombus) 08/2017 - 01/2015
2	Hypersensitivity (Allergy) 01/2017 - 03/2016
2	Ischemic Stroke 03/2014 - 10/2009
2	Infarction (Infarctions) 03/2014 - 10/2012
2	Hypoxia (Hypoxemia) 10/2013 - 02/2010
2	Inflammation (Inflammations) 10/2012 - 09/2005
2	Rupture 09/2004 - 04/2004
1	Multiple Myeloma 05/2022
1	Peripheral Arterial Disease 10/2019
1	Vascular System Injuries 01/2018
1	Hyperthermia 08/2017
1	Hemolysis 01/2017
1	Carcinoma (Carcinomatosis) 06/2016
1	Melanoma (Melanoma, Malignant) 11/2015
1	Wounds and Injuries (Trauma) 01/2014
1	Hypertension (High Blood Pressure) 05/2013
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2012
1	Chest Pain (Chest Pains) 02/2012
1	Cerebral Infarction 10/2009
1	Pathologic Constriction (Stenosis) 10/2009
1	Autoimmune Diseases (Autoimmune Disease) 07/2006
1	Fibrosis (Cirrhosis) 04/2004

Drug/Important Bio-Agent (IBA)

6	Connective Tissue Growth FactorIBA 01/2014 - 04/2004
3	Pharmaceutical PreparationsIBA 01/2018 - 02/2010
3	Proteins (Proteins, Gene)FDA Link 08/2017 - 04/2004
3	CytokinesIBA 09/2013 - 02/2012
2	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2016 - 01/2016
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2014 - 10/2012
2	Oxygen (Dioxygen)IBA 10/2013 - 02/2010
2	Messenger RNA (mRNA)IBA 09/2013 - 05/2005
2	Telmisartan (Micardis)FDA Link 05/2013 - 01/2011
1	Ferrosoferric Oxide (Magnetite)FDA Link 10/2020
1	Arginine (L-Arginine)FDA Link 10/2020
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 10/2019
1	CholesterolIBA 01/2018
1	GlucocorticoidsIBA 01/2018
1	LipidsIBA 01/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018
1	GelsIBA 08/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	leukocyte procoagulant activityIBA 01/2017
1	Sepharose (Agarose)IBA 06/2016
1	Drug CarriersIBA 01/2016
1	DesminIBA 11/2015
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2015
1	Neuroprotective AgentsIBA 03/2014
1	SilverIBA 03/2014
1	src-Family KinasesIBA 01/2014
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 10/2013
1	Interleukin-6 (Interleukin 6)IBA 02/2012
1	Interleukin-8 (Interleukin 8)IBA 02/2012
1	Interleukin-13IBA 02/2012
1	ChemokinesIBA 02/2012
1	rho-Associated KinasesIBA 02/2010
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2010
1	fosbretabulin (combretastatin A4)IBA 02/2010
1	3'- O- (5'- phosphoryldeoxycytidyl)phosphorothioateIBA 10/2009
1	Inflammation MediatorsIBA 10/2009
1	IronIBA 06/2007
1	Coloring Agents (Dyes)IBA 06/2007
1	AutoantibodiesIBA 07/2006
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2005
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2005
1	HLA-DR Antigens (HLA-DR)IBA 09/2004

Therapy/Procedure

6	Therapeutics 05/2022 - 01/2015
2	Intravenous Administration 01/2017 - 03/2016
1	Radiotherapy 05/2022
1	Precision Medicine 10/2020
1	Injections 01/2017
1	Thrombolytic Therapy 08/2015
1	Stents 01/2015
1	Lasers (Laser) 02/2012